News
Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...
Recent health-related developments include Britain's decisions on the bioethanol industry, Berkshire Hathaway's new stake in ...
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
The disclosure in a filing Thursday gave a much-needed boost to the beleaguered health insurance giant, which saw shares jump as much as 9.6% in post-market trading. In other news: Nike co-founder ...
Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...
Berkshire Hathaway invests in UnitedHealth; FTC investigates Hims & Hers for advertising practices; U.S. health department ...
Stock index futures rose on Friday, with Dow futures leading the charge, as UnitedHealth got a boost after Berkshire Hathaway ...
11h
TipRanks on MSNHere’s Why Wall Street Is Cautious on Hims & Hers Health Stock (HIMS)
Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...
Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed the Federal Trade Commission has been investigating the telehealth ...
Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...
13h
TipRanks on MSNHims & Hers calls Bloomberg story on FTC probe ‘rehashed’
After Bloomberg reported, citing people familiar with the probe, that the Federal Trade Commission has been investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results